Brigette B. Ma
Brigette B. Ma
Chinese University of Hong Kong, Hong Kong
Dr Brigette Ma is currently Professor and Honorary Consultant at the Department of Clinical Oncology, Chinese University of Hong Kong (CUHK) and Honorary Professor, Department of Health Technology and Informatics, The Hong Kong Polytechnic University. She is also the Medical Director of the Phase I Clinical Trial Centre (Oncology) and Co-Director of the Cancer Drug Testing Unit at the Department of Clinical Oncology, Prince of Wales Hospital. She received her undergraduate degree with Honours at Monash University, Australia, and was awarded Fellow of the Royal Australasian College of Physicians (2001), Fellow of Hong Kong College of Physicians (2004), and Doctor of Medicine in 2014 (CUHK). She underwent training in Medical Oncology at the Peter MacCallum Cancer Institute, Melbourne, and was Research Fellow at the Princess Margaret Hospital, Toronto, Canada. She has published over 140 peer-reviewed papers and contributed to three book chapters. Notably, she is a Faculty member of the European Society of Medical Oncology (ESMO) in Gastrointestinal Cancer, and was a member of the Consensus Working Group for the management of metastatic colorectal cancer; executive member of the National Cancer Institute (Bethesda, USA) Head and Neck Cancer Steering Committee - Clinical Trials Planning Group on Nasopharyngeal Cancer, Co-chair of Widely Metastatic Group (since 2017); and mentor and committee member of the Women in Cancer Research of the American Association of Cancer Research (since 2016). Her other current roles include: member of the Joint Scientific Committee for Phase 1 Clinical Trials, Centre of Health Protection, Hong Kong Hospital Authority; Chair/ member of the Scientific Committee at the 2016 American Association of Cancer Research at New Orleans, USA, ESMO – GI cancer meeting in Barcelona (2017 & 2018).